Allison Dorval Verve Therapeutics, Inc. (VERV) insider trading activity
Allison Dorval is Chief Financial Officer of Verve Therapeutics, Inc.. Currently has a direct ownership of 13,280 shares of VERV, which is worth approximately $148,337. The most recent transaction as insider was on Apr 02, 2025, when has been sold 3,350 shares (Common Stock) at a price of $4.15 per share, resulting in proceeds of $13,902. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13.3K
146.84%
3M change
227.09%
12M change
Total Value Held
$148,337
Allison Dorval Transaction History
Also insider at
AD
Allison Dorval
Chief Financial Officer
Cambridge, MA